Simon Glairy is a visionary in the Insurtech space, specializing in how data and proactive risk assessment can fundamentally reshape our relationship with health. With a career dedicated to bridging the gap between traditional insurance models and cutting-edge technology, he offers a unique vantage point on the evolution of the industry. We are sitting down to discuss the recent news surrounding the health platform Alan, a powerhouse that just secured €480 million in Series G funding to redefine what it means to be covered. By shifting the focus from treating illness to maintaining wellness, Glairy explores how this new category of “prevention insurance” is set to transform the European and global markets.
Traditional health coverage often waits for symptoms to worsen before intervening. How does shifting toward a prevention-focused model fundamentally change the relationship between an insurer and its members?
This shift transforms the insurer from a silent bill-payer into a proactive partner that is deeply invested in a member’s daily vitality. By moving away from a reactive “wait and see” approach, the model focuses on early intervention to ensure health concerns do not escalate into life-altering crises. When you serve more than 1.1 million members and 37,000 businesses, you quickly realize that people are tired of waiting for a six-month appointment or struggling through a system that only catches up when things go wrong. For the past decade, the goal has been to show that technology can turn healthcare into a proactive experience where wellbeing services are accessible at your fingertips. It creates a sense of security because the platform helps people act early instead of reacting late, making healthcare feel like a universal right rather than a bureaucratic hurdle.
With the recent €480 million financing round, AI is clearly a cornerstone of this growth strategy. In what ways can artificial intelligence make personalized prevention scalable for millions of people without losing the human touch?
AI acts as the essential connective tissue that makes personalized care navigation affordable and accessible to a massive, diverse population across France, Belgium, Spain, and Canada. It allows for an integrated platform where AI-powered health assistance can analyze individual data points to provide tailored advice that previously would have required a massive team of specialists. This technology isn’t just about efficiency; it’s about making sure that whether you are a self-employed professional or a retiree, you receive guidance that feels specific to your life. The real magic happens when AI reduces the long-term cost of care while simultaneously improving outcomes, proving that technology can be deeply empathetic by ensuring no one falls through the cracks.
Alan has secured a massive valuation of €5.5 billion and is looking toward further international expansion. What specific advantages does a partnership with a global investor like Prosus bring to a company trying to export this new category of insurance?
Partnering with an investor like Prosus provides more than just the capital from a $550 million round; it offers a roadmap for navigating complex international consumer markets. Prosus brings a deep well of expertise in international expansion and consumer products, which is vital when you are trying to break into new territories with a completely new category of health service. The goal is to use this fresh capital to deepen the company’s foothold in its existing four countries while identifying strategic acquisitions that can accelerate growth elsewhere. There is a palpable shift in the ecosystem when a platform integrates insurance, prevention, and care delivery so seamlessly that it creates exceptional engagement. This partnership is designed to unlock that value globally, ensuring the infrastructure is robust enough to handle the unique regulatory nuances of each new market.
What is your forecast for the future of the Insurtech industry as it moves toward these integrated health platforms?
I foresee a complete dismantling of the siloed healthcare experience, where insurance is no longer a separate entity from care delivery. We are moving toward a world where every major player will have to adopt a proactive stance, or they will simply be left behind by more agile, tech-driven competitors. The success of this massive financing round signals to the market that prevention insurance is not just a niche experiment, but the future standard for how health is managed globally. Within the next few years, we will see these integrated platforms become the primary gateway for healthcare, where technology handles the routine navigation and humans focus on high-level, specialized care. It is a future where the system finally catches up to the patient, rather than the patient perpetually waiting for the system.
